Trump Lashes Out At Pfizer Over Its Price Hikes, But Latest Round Of Posturing Earns Mostly A Shrug

Meanwhile, HHS Secretary Alex Azar also promised change was coming to the industry “whether it’s painful or not for pharmaceutical companies.” But the daunting reality of overhauling the drug pricing system may stand in the way of that message.

Leave a Reply

Your email address will not be published. Required fields are marked *